Winston Dunn

Winston Dunn

Company: University of Kansas Medical Center

Job title: Professor

Seminars:

2:00 pm Roundtable Discussion: Navigating the Future of MASH Drug Development in the GLP-1 Era From Biopsy to Biomarker 2:00 pm

A Paradigm Shift in Trial Design – The recent FDA acceptance of a non-invasive biomarker as a surrogate endpoint is a pivotal moment for drug development, which is set to transform clinical trials by reducing patient burden, improving recruitment and retention, and accelerating the path to regulatory approval for new therapies The New Therapeutic Foundation…Read more

day: Conference Day 2

2:45 pm Leveraging Biomarkers for Efficient MASH Patient Stratification to Reduced Screen-Failures in Clinical Trials 2:45 pm

Reviewing simple biomarkers to pre-screen patients for liver directed therapy and clinical trials Using advanced biomarkers to screen-patients for clinical trials and reduce screen-fail rateRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.